| 润迈德医疗有限公司, 02297.HK - 公司概览 |
| 集团主席 |
霍云飞 |
| 发行股本(股) |
1,167,000,000 |
| 面值币种 |
港元 |
| 股票面值 |
1.0E-4 |
| 行业分类 |
- |
| 公司业务 |
集团致力成为全球领先的血管介入手术机器人公司，目前专注於基於冠状动脉造影的血流储备分数系统（「caFFR系统」）及基於冠状动脉造影的微血管阻力指数系统（「caIMR系统」）的设计、开发及商业化。 |
资料来源于上市公司财务报表
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window